Targeting Endothelial HIF2α/ARNT Expression for Ischemic Heart Disease Therapy
K Ullah, L Ai, Z Humayun, R Wu - Biology, 2023 - mdpi.com
Simple Summary In this review paper, we discuss potential new therapies for ischemic heart
disease (IHD), a leading cause of death and disability around the world. IHD results from a …
disease (IHD), a leading cause of death and disability around the world. IHD results from a …
Single-cell insights: pioneering an integrated atlas of chromatin accessibility and transcriptomic landscapes in diabetic cardiomyopathy
Q Su, W Huang, Y Huang, R Dai, C Chang… - Cardiovascular …, 2024 - Springer
Background Diabetic cardiomyopathy (DCM) poses a growing health threat, elevating heart
failure risk in diabetic individuals. Understanding DCM is crucial, with fibroblasts and …
failure risk in diabetic individuals. Understanding DCM is crucial, with fibroblasts and …
[PDF][PDF] Targeting Endothelial HIF2α/ARNT Expression for Ischemic Heart Disease Therapy. Biology 2023, 12, 995
K Ullah, L Ai, Z Humayun, R Wu - 2023 - academia.edu
Ischemic heart disease (IHD) is a major cause of mortality and morbidity worldwide, with
novel therapeutic strategies urgently needed. Endothelial dysfunction is a hallmark of IHD …
novel therapeutic strategies urgently needed. Endothelial dysfunction is a hallmark of IHD …